OptiBiotix Health (FRA:OB3) Tax Provision : €0.16 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is OptiBiotix Health Tax Provision?

OptiBiotix Health's tax provision for the six months ended in Jun. 2023 was €0.01 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2023 was €0.16 Mil.

OptiBiotix Health Tax Provision Historical Data

The historical data trend for OptiBiotix Health's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Tax Provision Chart

OptiBiotix Health Annual Data

Trend

Jul10

Jul12

Nov14

Nov15

Nov16

Nov17

Nov18

Dec20

Dec21

Dec22

Tax Provision

Get a 7-Day Free Trial

0.26

0.06

0.10

0.17

OptiBiotix Health Semi-Annual Data
	Jul12	Jan13	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Tax Provision	Get a 7-Day Free Trial															-	0.10	0.01	0.15	0.01

OptiBiotix Health Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.16 Mil.

OptiBiotix Health (FRA:OB3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (FRA:OB3) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

OPTI.GB:UK OPTI:UK

Address

Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG

Website

https://www.optibiotix.com

OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.

OptiBiotix Health (FRA:OB3) Headlines

No Headlines